Journal details
DIABETES TECHNOLOGY & THERAPEUTICS
SAGE PUBLICATIONS INC · ISSN 1520-9156 · eISSN 1557-8593
SCIEScopusMEDLINEPubMedPMC
Overview
DIABETES TECHNOLOGY & THERAPEUTICS. ISSN 1520-9156 · eISSN 1557-8593. published by SAGE PUBLICATIONS INC. United States. Endocrinology & Metabolism. impact factor 7.4 (2025). JCR Q1. CAS Zone 2. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 115 articles · 2025: 215 articles · 2024: 157 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of DIABETES TECHNOLOGY & THERAPEUTICS?
The impact factor recorded for DIABETES TECHNOLOGY & THERAPEUTICS is 7.4 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of DIABETES TECHNOLOGY & THERAPEUTICS?
DIABETES TECHNOLOGY & THERAPEUTICS is listed in CAS Zone 2.
Which databases index DIABETES TECHNOLOGY & THERAPEUTICS?
DIABETES TECHNOLOGY & THERAPEUTICS is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.